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Background
Early re-admission after hospitalization is an increasing
focus of health-care policy because it results in high costs
and often reflects opportunities for improving treatment
quality. The goal of this study is to examine the relation-
ship between 30-day mental health/substance use disorder
hospital re-admission for persons with schizophrenia, and
patient characteristics, hospital utilization, and community
treatment quality and capacity.
Materials and methods
Observational study of schizophrenia-diagnosed enrol-
lees having ≥ 1 behavioral health hospitalization in 2005
from 18 state Medicaid programs (N = 28083). Regres-
sion models examined the relationship between 30-day
behavioral health hospital re-admission, enrollee charac-
teristics (demographic and comorbidity), and county-
level indicators for: 1) quality of care (antipsychotic and
behavioral health visit continuity, behavioral health visit
within 7 days post-hospitalization); 2) behavioral health
hospitalization (length of stay, admission rates); and
3) treatment capacity (e.g., population-based estimates
of outpatient providers/clinics).
Results
Fifty-one percent of the study population had a co-
occurring substance use disorder; nearly 47 percent had
a co-occurring chronic general medical condition. Enrol-
lee comorbidity was associated with higher predicted
probability of 30-day behavioral health re-admission,
particularly for enrollees with substance use disorders
(predicted probability [95% CI] = 23.9% [21.5%–26.3%])
versus without (14.7% [13.9%–15.4%]). Chronic medical
conditions were associated with increased re-admissions
in a dose-response manner (e.g., ≥ three: 25.1% [22.1%–
28.2%] versus none: 17.7% [16.3%–19.1]). Higher county
rate of behavioral health visits within 7 days post-hospi-
talization was associated with lower re-admission for
individual enrollees (e.g., for county rates of 7-day
follow-up of 55% versus 85%, re-admission predicted
probability = 16.1% [15.8%–16.4%] versus 13.3% [12.9%–
13.6%]). In contrast, higher county rate of behavioral
health hospitalization was associated with higher re-
admission probability for individual enrollees (e.g., for
country admission rates 10% versus 30%, re-admission
predicted probability for an individual = 11.3% [11.0%–
11.6%] versus 16.7% [16.4%–17.0%]).
Conclusions
Efforts to reduce 30-day psychiatric re-admissions should
focus on comorbid substance use and general medical
care coordination, as well as factors that contribute to
hospitalization in general and improving transitions to
community care. Comorbid substance use disorders were
particularly prominent in 30-day behavioral health re-
admission—patients with comorbid substance use disor-
ders had a 63.7 percent higher predicted probability of
30-day re-admission compared to those without. These
findings demonstrate the substantial role of comorbid
substance use disorders in behavioral health 30-day re-
admissions. They also highlight an opportunity for Medi-
caid policy to influence improved access to substance use
disorder treatment, including its coordination with beha-
vioral health and general medical care, in an effort to
reduce 30-day re-admission for individuals with severe
mental illness.
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